EUVIMEDEUVIMED entdecken
Open Access

Pan-enteric Capsule Endoscopy in Crohn’s Disease: Impact on Therapeutic Decisions and Inter-observer Agreement in a Multicentre Case-based Study

Carlo Calabrese iD, Nikolas Dussias, Fernando Rizzello, Paolo Gionchetti, Alessandro Armuzzi, Marco Daperno, Antonio Rispo, Chiara Ricci, Francesco Simone Conforti, Patrizia Alvisi, Erasmo Miele, Matteo Bramuzzo und 3 weitere

Endoscopy International Open · 03.06.2026 · 14 (CP)

DOI: 10.1055/a-2877-2224 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endoscopy International Open, erschienen am 03.06.2026. Verfasst von Carlo Calabrese und 14 weiteren Autor:innen. Beteiligte Einrichtung: Scientific DirectorateIRCCS Centro di Riferimento Oncologico della BasilicataRionero In VulturePotenzaItaly. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and study aims Pan-enteric capsule endoscopy (CE) provides a comprehensive mucosal assessment of both the small bowel and colon in Crohn’s disease (CD). However, its incremental impact on structured clinical decision-making and inter-observer agreement remains insufficiently defined. We aimed to evaluate whether the availability of CE findings influences therapeutic decisions, risk stratification and monitoring strategies in patients with CD. Patients and methods We performed a multicentre, retrospective, paired case-based study including 50 real-world CD cases (35 adults, 15 paediatric). For each case, two anonymised vignettes were generated: one incorporating clinical, biochemical and cross-sectional imaging data without CE, and one additionally including CE findings. Ten experienced inflammatory bowel disease (IBD) gastroenterologists (six adult, four paediatric) independently reviewed all vignettes in randomised order using a structured questionnaire. The primary outcome was change in therapeutic decision-making after disclosure of CE findings. Secondary outcomes included changes in risk stratification, assessment of treatment efficacy, timing of follow-up, confidence in decision-making and inter-observer agreement.

Results

Access to CE findings significantly modified risk assessment and treatment selection. Overall, 53.3% of risk-stratification responses and 56.7% of treatment decisions changed, with a consistent shift towards higher perceived risk and treatment escalation (p < 0.0001 for both). CE also altered monitoring strategies, increasing reliance on endoscopic/CE-based assessment (change rate 36.7%; p < 0.0001), and modestly shortened planned follow-up intervals (change rate 18.5%; p = 0.0366). Confidence scores showed no significant overall shift (p = 0.2700), despite 41.6% of individual ratings changing. Inter-observer agreement improved from fair to moderate across several domains when CE results were available. No cases with isolated colonic CD were included in the final case set, and no capsule retention occurred in the included cohort.

Conclusions

In this multicentre paired case-based study, pan-enteric CE substantially influenced risk stratification, treatment selection and monitoring plans in CD, while improving inter-observer agreement across several decision domains. These findings indicate that CE meaningfully affects structured clinical decision-making in selected patients, particularly when small-bowel involvement is suspected or when conventional investigations are discordant. Prospective longitudinal studies are needed to determine whether CE-guided decisions translate into improved clinical outcomes.

Schlagwörter

Stichwörter der Autor:innen

GI pathologyendoscopy lower GI tractendoscopy small bowelinflammatory bowel diseaseother focus (of reviewers)

Autor:innen und Institutionen

  • Scientific DirectorateIRCCS Centro di Riferimento Oncologico della BasilicataRionero In VulturePotenzaItaly.
  • Department of Medical and Surgical Sciences, IBD UnitIRCCS Azienda Ospedaliero-Universitaria di Bologna Policlinico di Sant'OrsolaBolognaEmilia-RomagnaItaly.
  • IBD Unit, Department of GastroenterologyIRCCS Humanitas Research HospitalRozzanoLombardiaItaly.
  • Department of Biomedical SciencesHumanitas UniversityMilanoItaly.
  • Gastroenterology UnitAO Ordine MaurizianoTorinoItaly.
  • Gastroenterology, Department of Clinical Medicine and SurgerySchool of Medicine "Federico II" of NaplesNaplesCampaniaItaly.

ORCID-Profile: Carlo Calabrese, Gian Eugenio Tontini

Zitieren

APA

Calabrese, C., Dussias, N., Rizzello, F., Gionchetti, P., Armuzzi, A., Daperno, M., Rispo, A., Ricci, C., Conforti, F. S., Alvisi, P., Miele, E., Bramuzzo, M., Propato, R., Oliva, S., & Tontini, G. E. (2026). Pan-enteric Capsule Endoscopy in Crohn’s Disease: Impact on Therapeutic Decisions and Inter-observer Agreement in a Multicentre Case-based Study. Endoscopy International Open, 14(CP). https://doi.org/10.1055/a-2877-2224

Vancouver

Calabrese C, Dussias N, Rizzello F, Gionchetti P, Armuzzi A, Daperno M, et al. Pan-enteric Capsule Endoscopy in Crohn’s Disease: Impact on Therapeutic Decisions and Inter-observer Agreement in a Multicentre Case-based Study. Endoscopy International Open. 2026;14(CP). doi:10.1055/a-2877-2224

BibTeX
@article{Calabrese2026,
  author = {Calabrese, Carlo and Dussias, Nikolas and Rizzello, Fernando and Gionchetti, Paolo and Armuzzi, Alessandro and Daperno, Marco and Rispo, Antonio and Ricci, Chiara and Conforti, Francesco Simone and Alvisi, Patrizia and Miele, Erasmo and Bramuzzo, Matteo and Propato, Rossella and Oliva, Salvatore and Tontini, Gian Eugenio},
  title = {Pan-enteric Capsule Endoscopy in Crohn’s Disease: Impact on Therapeutic Decisions and Inter-observer Agreement in a Multicentre Case-based Study},
  journal = {Endoscopy International Open},
  year = {2026},
  volume = {14},
  number = {CP},
  doi = {10.1055/a-2877-2224}
}
Kostenlos starten →